A procedure is presented for isolating the nucleocapsid proteins, N and NP from vesicular stomatitis virus and Sendai virus respectively, in soluble form. These proteins were suitable for the determination of their blocked amino-terminal peptide sequences by gas-liquid chromatography/mass spectrometry at the low nanomole level. The N protein prepared by this procedure was previously shown to retain some of its expected biological activity. The sequence of 626 nucleotides from the 3' end of the Sendal virus genome, which includes the first one-third of the NP gene, was determined. Using this information, primer extension studies on intracellular Sendai virus mRNAs allowed the determination of the structure of the leader-NP intervening sequence and the 5' end of the NP mRNA. Comparison of the amino termini of the nucleocapsid proteins with their respective mRNA sequences revealed that these proteins are similarly processed in vivo.
INTRODUCTION
The non-segmented minus-strand (-) RNA genome of the rhabdovirus vesicular stomatitis virus (VSV), and that of the paramyxovirus Sendal virus, are always found tightly complexed in helical nucleocapsid structures with their respective viral nucleocapsid proteins, N and NP. The nucleocapsid structure protects the genomes from nuclease attack, and in conjunction with two less tightly associated viral proteins which constitute the viral RNA polymerase (NS and L of VSV: Emerson & Yu, 1975; P and L of Sendal: Stone et al., 1972; Marx et al., 1974; Lamb & Mahy, 1975) , displays all the enzyme activities required for synthesis of the viral mRNAs (Banerjee et al., 1977; Kingsbury, 1974) .
Because the nucleocapsids are of central importance in both virus structure and replication, it would be of interest to study the properties of the purified nucleocapsid proteins themselves. However, previous attempts to isolate the N protein from nucleocapsids by treatment with dimethyl urea (S. Emerson, personal communication) or with guanidinium salts (G. Wertz, personal communication) have resulted in preparations with intractable physical properties. Both proteins can be removed from their nucleocapsids by treatment with SDS or phenol, but these reagents are likely to denature the protein. The viral nucleocapsids are also stable to highsalt conditions. Indeed, banding in CsC1 gradients at a buoyant density of 1.33 g/ml (2-5 M-CsC1) is diagnostic for VSV and Sendai virus nucleocapsids, for under these conditions all other cellular RNA-protein complexes disaggregate (Leppert et al., 1979) . Thus, although these proteins are major components of the mature virion (Wagner et al., 1969; Mountcastle et al., 197t) , they have resisted attempts at purification. In this paper, we describe a simple procedure for the isolation of N and NP proteins from intracellular nucleocapsids, based on CsCI density gradient centrifugation in the presence of guanidinium chloride.
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0022-1317/84/0000-5995 $02.000 1984 SGM The VSV N protein prepared by this procedure was previously shown to self-assemble in the absence of RNA, to assemble RNAs into nucleocapsid-like structures, and in particular to selectively encapsidate VSV leader RNA over mRNAs . The selectivity of this encapsidation is thought to reside in the nucleation reaction, i.e. the association of N protein with the sequence of the first 14 nucleotides at the 5' end of the VSV leader RNA. The subsequent elongation of nucleocapsids is thought to result from the cooperative binding of free N protein with that already assembled in the initiated complex and to be sequence-independent. In order to study the nucleocapsid assembly process more closely, it is essential to know the structure of the N and NP proteins, since different forms of these proteins may play different roles in the assembly mechanism.
Like many cytoplasmic proteins (Wold, 1981) , the Sendai virus NP protein is N~-blocked and refractory to sequencing (Heggeness et al., 1981) . By adopting a gas-liquid chromatography/ mass spectrometry (GLC-MS) micromethod recently developed by Rose et al. (1983 b) , we were able to determine the blocked amino-termini peptide sequences of both the VSV N and the Sendai virus NP proteins (Rose et al., 1983a) . The basic technique (Gray & del Valle, 1970) involves acetylation, protease digestion and permethylation of the protein to produce volatile derivatives suitable for mass spectrometry. The GLC-MS techniques of Rose et al. (1983a, b) should therefore be of general interest, as sequence information can be obtained directly from 2 to 5 nmol of proteins with blocked amino terminal. In this paper we report the DNA sequence of the first one-third of the Sendai virus NP gene; the VSV N gene sequence has been published (Gallione et al., 1981) . Comparison of the peptide and mRNA gene sequences shows that both proteins have been similarly processed, by cleavage of the initiating methionine and N ~-acetylation of the following amino acid. In addition, primer extension experiments and other data described here define the 5' end of the NP mRNA and help to define the nature of the Sendai leader-NP gene intervening sequence.
METHODS
Preparation of infected cell cytoplasmic extract. BHK21 cells in minimal essential medium (MEM) + 5~ foetal calf serum were infected with standard Indiana serotype VSV (Mudd Summers strain) or Sendai virus (Harris strain) at an m.o.i, of 10 and grown at 33 °C until c.p.e, was evident in the entire cell population. Cytoplasmic extracts were prepared as previously described (Leppert et al., 1979) . Buffers used were as follows. ET: 10 mMTris HCI pH 7-4, 1 mM-EDTA; TNE: 20 mM-Tris-HCI pH 7.4, 100 mM-NaC1, 1 mM-EDTA. For radiolabelling, [3H]uridine or [3sS]methionine were added.
Preparation of VS V Nprotein. Cytoplasmic extracts were prepared from VSV-infected cells at a concentration of 25 × 106 cells/ml (Leppert et al., 1979) , and 9 ml portions of the extract were centrifuged on 20 ml, 20 to 40~ CsC1 gradients containing ET, overlaid with 7 ml of 5 ~o sucrose containing TNE, for 3 h at 25 000 rev/min in the SW28 rotor at 15 °C. During this relatively short centrifugation, the viral nucleocapsids (approx. 200S) approach their buoyant density before other cellular or viral components. This single step thus provided a band of relatively pure nucleocapsids containing mainly the viral N protein, since the high CsC1 concentration removes the NS and L proteins (Szilagyi & Uryvaev, 1975) .
The visible nucteocapsid band (t-33 g/m/) was removed by puncturing the side of the tube, diluted threefold with ET, layered directly onto a second 20 ml, 20 to 40~ CsCI gradient containing 3 M-guanidiniu m chloride, and re-centrifuged for a longer time so that the viral RNA could pellet. After centrifugation for 18 h at 27000 rev/min in the SW28 rotor at 15 °C, two bands in the middle of the gradient were visible: a minor band at the position of intact nucleocapsids, and a major band at a density of 1.26 to 1.28 g/ml, corresponding to the position of the 35S-labelled protein in Fig. 1 . The upper band was removed through the side of the tube and vacuum-dialysed at 0 °C against three changes of 50 mM-Tris HCI pH 7.8, 1 M-NaC1, 1 mM-EDTA. After clarification by low-speed centrifugation, the final protein concentration was 1 to 2 mg/ml. The N protein prepared by this procedure could be stored as a clear solution for months at 0 °C in 1 M-NaCI at pH 7.8. Warming the clear solution to room temperature or lowering the pH to 6.5 resulted in visible opalescence due to the self-assembly of the protein into helical structures, even in the absence of RNA . In a typical preparation approximately 1.2 x 109 VSV-infected cells (harvested 16 to 18 h post-infection) yielded 2 to 4 mg of soluble N protein.
Sequencing of the first one-third of the Sendai virus NP gene. The Sendai virus genome was cloned into pBR322, and a series of overlapping plasmids was determined to represent the NP, P/C, and M genes (Dowling et al., 1983 ; Giorgi et al., 1983b) . Both strands of appropriate restriction fragments from NP gene clones SL-3 and SL-11 (Dowling et al., 1983) were sequenced by the Maxam & Gilbert (1980) procedure. The sequence was extended to the 3' end of the genome by direct RNA sequencing (Giorgi et al., 1983a; Dowling et al., 1983) .
were isolated from polyacrylamide gels as dsDNA, and 5' end-labelled by means of T4 polynucleotide kinase and [V-32p]ATP after pretreatment with alkaline phosphatase. For aqueous annealing, 20000 ct/min of the labelled restriction fragment was mixed with RNA in 6 p.1 water and heated for 2 rain at 90 °C. After addition of 2 ~tl 0.8 ~t-NaC1, the solution was annealed 15 rain at 60 °C. For forrnamide annealing, 20 000 ct/min of the labelled restriction fragment was mixed with RNA in 75/al of a solution containing 80% formamide, 0.4 M-NaCI, 10 m~-PIPES pH 6-4, 1 mM-EDTA, heated 10 min at 60 °C and annealed 2 h at 49 °C. The nucleic acids were then ethanol-precipitated and re-dissolved in 6 ttl H20. After annealing, the primers were extended in 20 ~tl reactions containing 50 mM-Tris-HCl pH 8-3, 10 mM-MgClz, 50 mM-NaC1, 5 mM-dithiothreitol, 500 nM each of dATP, dGTP, dCTP and TTP, and 10 units of avian myeloblastosis virus reverse transcriptase (Life Sciences, St Petersburg, Fla., U.S.A.), by incubation for 10 rain at 37 °C then for 30 rain at 42 °C. Nucleic acids were recovered by ethanol precipitation and analysed by polyacrylamide gel electrophoresis.
RESULTS

Preparation and analysis of N and NP proteins
Some time ago, we looked for possible differences between VSV virion and intracellular nucleocapsids by examining their stability to increasing concentrations of guanidinium chloride during centrifugation on CsC1 gradients. Although little or no difference in the relative stability of these nucleocapsids could be found, we determined that the presence of 3 M-guanidinium chloride in the CsC1 gradients was sufficient to deproteinize the viral nucleocapsids. Fig. 1 demonstrates this point. When intracellular nucleocapsids labelled either with [3 H]uridine or with [35 S]methionine were centrifuged on such gradients, the 3 H-labelled RNA sedimented to the pellet, whereas the 3sS-labelled protein now banded at the buoyant density of free protein (1.28 g/ml). Intact nucleocapsids, which would band at 1.33 g/ml (fraction 6), were almost entirely absent. (Leppert et al., 1979) . A 250 ~1 portion of each pool of labelled nucleocapsids was then layered onto a 3.7 ml, 20 to 40~ CsC1 gradient in ET buffer plus 3 M-guanidinium chloride. After centrifugation for 16 h at 55000 rev/min in the SW60 rotor at 15 °C, the gradients were collected by pumping through a capillary tube so as not to disturb the pellet and the bottom 200 ~tl, which together are considered the pellet fraction. Aliquots of each gradient fraction were counted by liquid scintillation for 3H (O) and 3sS (O). This finding formed the basis for the purification of VSV N protein (see Methods). Subsequently, we have also prepared the analogous Sendai virus NP protein by this procedure, as experiments of Mountcastle et al. (1970) suggested that CsC1 gradient centrifugation removes the L and most of the P proteins from the nucleocapsid. Fig. 2 shows electropherograms of VSV N and Sendai virus NP proteins. On occasion, the VSV N protein contained a small amount of the viral NS protein (see Fig. 2, lane 3) . Interestingly, such preparations did not contain detectable levels of either protein kinase or nucleotide phosphohydrolase activity when assayed in the presence of [y-32p]ATP (data not shown).
The VSV N protein prepared as above proved to be suitable for direct amino terminus analysis by a modification of a recently developed micromethod involving GLC-MS (Rose et al., 1983 b) . The mass spectrum obtained from the VSV N protein showed the blocked tripeptide N ~-acetyl-Ser-Val-Thr (Rose et al., 1983 a) . In the VSV N gene sequence reported by Gallione et al. (1981) , the tripeptide Ser-Val-Thr appears only immediately following the initiating Fig. 3 shows that this blocked tetrapeptide corresponds only to the tetrapeptide Ala-Gly-Leu-Leu which also immediately follows the initiating methionine. Hence, within the limits of our sequence information, the Sendai virus protein is processed in vivo similarly to the VSV N protein.
Analysis of the Sendai virus leader and NP gene region
In VSV transcripti0n~ the first and most abundant product is the 47 bp 'leader' RNA, followed by the capped mi~NAs all of which start with the sequence 5'-AACAG... (Kozak, 1983) . While this work was in progress, Shioda et aL (1983) reported the sequence of the first 3687 nucleotides from the 3' end of the Sendai virus Z strain genome, including the complete NP gene. The corresponding region of their sequence differs from that in Fig. 3 by four nucleotides in the leader region, and nine in the NP gene that lead to seven amino acid changes. In their sequence also, the tetrapeptide Ala-Gly-Leu-Leu occurs only immediately following the initiating methionine. The position of the 5' end of the Sendai virus NP mRNA on the viral (-) genome was determined by primer extension of end-labelled restriction fragments isolated from clones of the NP gene using CsCI pellet RNA from Sendai virus-infected cells as a source of viral mRNA. The data using two of these fragments, the RsaI 149'mer (position 236 to 384 from the 3' end of the genome) and the HaelII 86'mer (position 123 to 208) are shown in Fig. 4 . Lanes 2 to 4, and 5 and 6 respectively of Fig. 4(a) show the results of extending the RsaI 149'met on both uninfected and Sendai virus-infected LLCMK2 cell CsC1 pellet RNA under different annealing conditions. In both cases, a single strong band, of approximately 325 bp, resulted only when Sendai virusinfected cell RNA was used, thus placing the end of the NP mRNA about 59 nucleotides from the 3' end of the genome. Other smaller bands, which are present when both uninfected and infected cell RNA was used and which vary in intensity from lane to lane, probably represent primer self-extension since they are not present in the end-labelled primer preparation (not shown).
In order to determine more accurately the 5' end of the NP mRNA, we next used the HaeIII 86'mer since this fragment is closer to the mRNA start. Lanes 2 and 3, and 4 and 5 respectively of Fig. 4 (b) show the results of the extension of this primer on both uninfected and Sendai virusinfected LLCMK2 and BHK cell CsC1 pellet RNA. Again, a single band, which in this case comigrated with the 154 bp HinfI marker, was present only when infected cell RNA was used, placing the end of the N P mRNA about 54 nucleotides from the 3' end of the genome. Fig. 4 (b) also demonstrates that Sendai virus-infected BHK cells contain approximately three times more NP mRNA than LLCMK2 cells, a result consistent with the enhanced ability of the BHK cell CsC1 pellet RNA to direct the translation of the NP protein in vitro (our unpublished data).
Taken together, the results so far place the 5' end of the Sendai virus NP mRNA at approximately position 54 to 59 from the 3' end of the (-) genome. Examination of the DNA sequence in this region shows the sequence 5'-AGGGTCAAAG starting at position 56. The Sendai P/C mRNA has been shown by dideoxynucleotide sequencing to start with the similar sequence 5'-AGGGTGAAAG, and this decanucleotide was also found at the beginning of the M gene Dowling et al., 1983) . In addition, we have determined that the vast majority of Sendai virus mRNAs made in a virion polymerase reaction in vitro begin 7 MeGpppA (our unpublished results). It therefore seems probable that the Sendai virus NP mRNA starts on the A residue at position 56 from the 3' end of the (-) genome. Fig. 4 (a) (lane 7) and (b) (lane 6) also show the results of primer extension of the RsaI 149'mer and the HaeIII 86'mer on an estimated 0.5 ~tg of the total RNA products of an in vitro Sendai virion polymerase reaction. Note that NP mRNA made in vitro appears to start at the same position as cytoplasmic NP mRNA, but that in each case a second larger band containing approximately 55 additional nucleotides is found, suggestive of a read-through transcript of leader and NP mRNA. This suggestion was confirmed by primer extension on intracellular nucleocapsid 50S RNA, a mixture of (-) genomes and (+) antigenomes. The signals are weak due to the presence of excess (-) genome RNA, but note that the putative read-through band, which appears as a doublet in lane 7 of Fig. 4(a) , is also found as an identical doublet in lane 8 (arrow). The band in lane 7 of Fig. 4(b) is very weak on this exposure, but note that the readthrough band in lane 6 is consistent with a length of 208 bp relative to the markers, i.e. it extends to the precise 3' end of the (-) genome. Interestingly, the read-through transcripts, which represent a sizeable fraction of the RNAs synthesized in vitro, cannot be detected among the intracellular RNAs at the exposures shown. Such read-through bands can sometimes be seen upon overexposure of the gels, but appear to represent less than 1% of the NP mRNA made in vivo.
DISCUSSION
We have utilized a combination of techniques for the preparation and direct amino terminus analysis of the nucleocapsid proteins of VSV and of Sendai virus. In conjunction with the predicted amino-terminal structures of the N and NP proteins derived from the DNA sequences, these techniques have enabled us to determine that the viral nucleocapsid proteins undergo cytoplasmic processing in the course of their synthesis and assembly into nucleocapsids. Minimally, this processing involves the removal of the initiating methionine followed by N ~-acetylation of the following amino acid. It should be noted that two-dimensional gels of the VSV nucleocapsid proteins show multiple spots, while the Sendai virus NP protein is phosphorylated (Roux & Kolakofsky, 1974; Lamb & Choppin, 1977; Raghow et al., 1978; Perrault et al., 1983) . It remains unclear whether the amino-terminal modifications we have described are present in all these different forms of the N and NP proteins. In addition, further work will clearly be required to determine whether all or only some of these different forms of N and NP are involved in the initiation, as opposed to elongation, of nucleocapsid assembly.
Besides the fact that the VSV and Sendai virus nucleocapsid proteins are processed at their amino termini and exist in multiple forms, it should also be noted that the biological activity imputed to N protein may not be due to this protein acting by itself. Pure N protein readily self-assembles, and protein expressed in vivo in cells transformed with a DNA clone of the VSV N gene was found to be highly aggregated and non-functional (Sprague et al., 1983) . Recent findings of R. Peluso & S. Moyer (personal communication) have indicated that cytoplasmic N protein exists as a complex with the VSV NS protein, which may be required to keep the free N protein in an active soluble form.
The work presented here has also localized the 5' end of the Sendai virus NP mRNA at position 56 from the 3' end of the (-) genome. Previous work has demonstrated that the major Sendai virus (+) leader RNA, made both in vivo and in vitro, was 55 nucleotides long (Leppert et al., 1979) . In that study, the length of the leader RNA was determined as dsRNA, by annealing leader RNA to a 3' end-labelled (-) genome RNA probe which was then digested with RNase A. Since the AAAA sequence at positions 52 to 55 of the (-) genome would not have been cleaved by this nuclease, the Sendai virus leader RNAs could have terminated anywhere within this four-base region. Thus, like VSV, the Sendai virus leader RNA terminates only a few nucleotides before the start of the nucleocapsid protein gene.
Recently, Keene and his coworkers have pointed out that the VSV (+) leader RNA appears to be separated into three functional domains (Kurilla et al., 1982) . The highly conserved 5'-proximal third of the leader RNA is thought to play a role in the initiation of RNA synthesis and in the nucleation of N protein assembly. The middle third contains a TATA-like sequence (Rose & Iverson, 1979) , and is thought to interact with virion polymerase components (Keene et aL, 1981) . The 3' proximal third may be involved in leader RNA termination, and it is this region that has been postulated to interact with cellular La proteins, which may represent a possible host factor in viral RNA synthesis (Wilusz et al., 1983; Kurilla & Keene, 1983) . Interestingly, the Sendai virus (+) leader RNA also fits the above description (see Fig. 3 ). The interaction of VSV leader RNAs with La protein in vitro has also focused attention on the similarities between VSV leader RNA and cellular and viral RNA polymerase III (pol III) transcripts (Weck & Wagner, 1979; McGowan et al., 1982) . Pol III transcripts are characterized by their relatively short length, lack of capping at their 5' end or polyadenylation at their 3' end, and by the finding that the primary pol III transcripts end with a series of U residues (Rinke & Steitz, 1982) . The Sendai virus (+) leader RNA also fits all of these criteria. It will therefore be of interest to determine whether the Sendai virus leader RNA also interacts with La protein in vivo and, if so, whether the leader-La complex plays a role with the N and NP proteins in the assembly of their respective nucleocapsids.
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